[P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD

Key facts

  • [P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD
  • P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.
  • Source: PR Times
  • Date: March 1, 2026

Direct answer

P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.

Citation
[P.E. Biopharm Corporation] 2026 Q1 EPS -1.18 NTD (March 1, 2026), PR Times
Source
PR Times
Date
March 1, 2026
P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.
その他NQ 0/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: March 1, 2026 at 09:00
  • 🔍 Collected: May 8, 2026 at 08:00 (1631h 0m after Published)
  • 🤖 AI Analyzed: May 8, 2026 at 08:13 (12 min after Collected)
Company Code: 6949
Company Name: P.E. Biopharm Corporation
Industry: Biotechnology and Medical Industry
Fiscal Year/Quarter: 2026 Q1
Basic Earnings Per Share (EPS): -1.18 NTD
Operating Revenue: 0.06 billion NTD
Net Profit After Tax: -0.87 billion NTD

FAQ

What are the key facts in this article?

P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.

What is the direct answer?

P.E. Biopharm Corporation reported a basic earnings per share (EPS) of -1.18 NTD for Q1 2026. The company's operating revenue was 0.06 billion NTD, and net profit after tax was -0.87 billion NTD, indicating a loss-making quarter.

What is the source and date?

PR Times: https://openapi.twse.com.tw/financial/twse-fin-6949-2026Q1 | March 1, 2026

Back to Newsroom (13)